论文部分内容阅读
目的研究治疗大面积脑梗时使用依达拉奉联合吡拉西坦的治疗效果。方法将50例脑梗塞患者随机分为两组:对照组(25例)、观察组(25例),对照组的脑梗患者在采用常规治疗的基础上使用吡拉西坦,观察组的脑梗患者则使用依达拉奉联合吡拉西坦。对两组患者治疗前后的疗效进行探讨分析。结果观察组的脑梗塞患者的总有效率明显高于对照组,两组比较差异有统计学意义。结论治疗大面积脑梗塞使用依达拉奉联合吡拉西坦效果十分明显,值得临床推广。
Objective To study the therapeutic effect of edaravone and piracetam in the treatment of large-area cerebral infarction. Methods Fifty patients with cerebral infarction were randomly divided into two groups: control group (25 cases), observation group (25 cases) and control group. Cerebral infarction patients were treated with piracetam on the basis of routine treatment, Edaravone is given in combination with piracetam. The two groups of patients before and after treatment to explore the effect of analysis. Results The total effective rate of patients with cerebral infarction in the observation group was significantly higher than that of the control group, the difference was statistically significant between the two groups. Conclusion The treatment of large area cerebral infarction with edaravone combined with piracetam effect is very obvious, worthy of clinical promotion.